Moolec Science SA announced positive results from the commercial-scale crushing of its U.S. GLASO1 safflower platform, achieving gamma-linolenic acid (GLA) concentrations of approximately 45%. This outcome follows the completion of Moolec's 2025 U.S. GLASO1 safflower campaign and represents a 57% year-over-year yield increase. The company reported that harvest performance materially exceeded internal forecasts and marked the first large-scale expansion of the GLASO1 platform from prior development and smaller-scale deployments to full commercial agricultural execution. Moolec indicated that these results position the company favorably in the U.S. nutrition and dietary supplements market, which values high-concentration functional lipids and plant-engineered, traceable ingredients. The company also emphasized its focus on maintaining cost and capital discipline while advancing toward repeatable commercial-scale production.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moolec Science SA published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1137502) on February 13, 2026, and is solely responsible for the information contained therein.